Alzheimer's disease is probably going to be treated by a cocktail of drugs.

In preventing or treating Alzheimer's disease and other degenerative conditions of the nervous system several new compounds that could play a role.

Cerebral emboli as a potential cause of Alzheimer's disease and vascular dementia.

Having close friends and staying in contact with family members offers a protective effect against the damaging effects of Alzheimer's disease.

The quantity of amyloid protein in brain cells is a major risk factor for Alzheimer's disease.

An enzyme previously associated with preventing the dementia of Alzheimer's disease now appears to play an even bigger role in safeguarding against the disease, bringing the promise of new targets for drug therapies.

New discovery is found to reduce beta amyloid; represents a promising advancement in treating this Alzheimer's disease.

Researchers have identified a potential new way to stop brain cell death related to Alzheimer's disease.

Research details exactly how a mutant form of the protein apolipoprotein E, also known as apoE, is a causative factor for Alzheimer's disease.

Taking medications to lower blood pressure, particularly those known as diuretics, may be associated with a lower incidence of Alzheimer's disease.

The Alzheimer's drugs Aricept, Razadyne and Exelon can lead to small improvements in mental functioning and the ability to carry out everyday activities in people with mild forms of the disease.

Reports from Alzheimer caregivers and observations by clinicians all indicated that memantine was beneficial to Alzheimer Disease patients.

The method may help to more accurately diagnose Alzheimer's disease, even before the appearance of cognitive symptoms, and to monitor disease progression.

Caregiver spouses of patients with Alzheimer's disease develop gum disease at twice the rate of their non caregiver counterparts.

Loss of body mass over time appears to be strongly linked to older adults' risk of developing Alzheimer's disease (AD), and the greater the loss the greater the chance of a person developing the disease, new research has found. The findings are the first to associate decline in body mass index (BMI) with the eventual onset of Alzheimer's disease. The researchers suggest that the loss of body mass reflects disease processes and that change in BMI might be a clinical predictor of the development of Alzheimer's disease.